1.
Menni F, De Lonlay P, Sevin C, et al: Neurological outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001;107:476–479.
2.
Glaser B, Thornton PS, Otonkoski T, Junien C: Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 2000;82:F79–F86.
3.
Aynsley-Green A, Hussain K, Hall JG, et al: Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 2000;82:F98–F107.
4.
Rahier J, Guiot Y, Sempoux C: Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed 2000;82:F108–112.
5.
Sempoux C, Guiot Y, Dahan K, et al: The focal form of persistent hyperinsulinemic hypoglycemia of infancy. Diabetes 2003;52:784–794.
6.
Fournet J, Mayaud C, De Lonlay P, et al: Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism. Am J Pathol 2001;158:2177–2184.
7.
Fournet J, Mayaud C, De Lonlay P, et al: Loss of imprinted genes and paternal SUR1 mutations lead to focal form of congenital hyperinsulinism. Horm Res 2000;53:2–6.
8.
De Lonlay P, Fournet J, Rahier J, et al: Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997;100:802–807.
9.
Brunelle F, Negre V, Barth MO, et al: Pancreatic venous samplings in infants and children with primary hyperinsulinism. Pediatr Radiol 1989;19:100–103.
10.
Dubois J, Brunelle F, Touati G, et al: Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol 1995;25:512–516.
11.
Lemmer K, Ahnert-Hilger G, Hopfner M, et al: Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells. Life Sci 2002;71:667–678.
12.
Giurgea I, Laborde K, Touati G, et al: Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinism. J Clin Endocrinol Metab 2004;89:925–929.
13.
Chigot V, De Lonlay P, Nassogne MC, et al: Pancreatic arterial calcium stimulation in the diagnosis and localisation of persistent hyperinsulinemic hypoglycaemia of infancy. Pediatr Radiol 2001;31:650–655.
14.
De Vroede M, Bax NM, Brusgaard K, Dunne MJ, Groenendaal F: Laparoscopic diagnosis and cure of hyperinsulinism in two cases of focal adenomatous hyperplasia in infancy. Pediatrics 2004;114:e520–522.
15.
Suchi M, Thornton PS, Adzick NS, et al: Congenital hyperinsulinism: intraoperative biopsy interpretation can direct the extent of pancreatectomy. Am J Surg Pathol 2004;28:1326–1335.
16.
Otonkoski T, Nänto-Salonen K, Seppänen M, et al: Noninvasive diagnosis of focal hyperinsulinism of infancy with 18F-DOPA positron emission tomography. Diabetes 2006;55:13–18.
17.
Ribeiro MJ, De Lonlay P, Delzescaux T, et al: Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med 2005;46:560–566.
18.
Lindstrom P: Aromatic-L-amino-acid decarboxylase activity in mouse pancreatic islets. Biochim Biophys Acta 1986;884:276–281.
19.
Oei HK, Gazdar AF, Minna JD, Weir GC, Baylin SB: Clonal analysis of insulin and somatostatin secretion and L-dopa decarboxylase expression by a rat islet cell tumor. Endocrinology 1983;112:1070–1075.
20.
Rubi B, Ljubicic S, Pournourmohammadi S, et al: Dopamine D2-like receptors are expressed in pancreatic β cells and mediate inhibition of insulin secretion. J Biol Chem 2005;280:36824–36832.
21.
Takasu A, Shimosegawa T, Shimosegawa E, et al: [11C]methionine positron emission tomography for the evaluation of pancreatic exocrine function in chronic pancreatitis. Pancreas 2001;22:203–209.
22.
Jager PL, Vaalburg W, Pruim J, de Vries EGE, Langen K, Piers DA: Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432–445.
23.
De Lonlay P, Fournet J, Touati G, et al: Heterogeneity of persistent hyperinsulinaemic hypoglycemia. A series of 175 cases. Eur J Pediatr 2002;161:37–48.
24.
Fekete CN, De Lonlay P, Jaubert F, Rahier J, Brunelle F, Saudubray JM: The surgical management of congenital hyperinsulinemic hypoglycemia in infancy. J Pediatr Surg 2004;39:267–269.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.